BTMD
Biote Corp -A
NASDAQ · Pharmaceuticals
$2.23
+0.11 (+5.19%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 23.18M | 22.38M | 21.94M |
| Net Income | 4.12M | 3.27M | 4.37M |
| EPS | — | — | — |
| Profit Margin | 17.8% | 14.6% | 19.9% |
| Rev Growth | -0.5% | -5.1% | +24.1% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 14.73M | 11.22M | 12.91M |
| Total Equity | 67.41M | 63.17M | 61.05M |
| D/E Ratio | 0.22 | 0.18 | 0.21 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 6.14M | 5.70M | 5.36M |
| Free Cash Flow | 3.06M | 2.62M | 2.18M |